← Back
Data updated: Jul 17, 2026
OHM LABS
Generics Pharmaceuticals
OHM LABS is a generic drug manufacturer with 10 FDA-approved products.
1985
Since
10
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
OHM LABS's Key Drugs
OHM LABS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
OHM LABS's Recent FDA Approvals
New NDA/BLA approvals for OHM LABS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
OHM LABS's Therapeutic Areas
Disease areas where OHM LABS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
OHM LABS Pipeline Snapshot
Active clinical trials for OHM LABS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1985-08-29
- Latest
- 2024-04-30
- Applications
- 13
FDA Sponsor Names
OHM LABSOHM LABS INCOHM